Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)
This study is ongoing, but not recruiting participants.
Study NCT01345240   Information provided by GlaxoSmithKline

First Received on April 28, 2011.   Last Updated on February 14, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Plasmodium Falciparum Malaria
Hepatitis B
Additional conditions recognized in this trial
Hepatitis
Hepatitis A
Malaria
Malaria, Falciparum
More general conditions related to this trial
Digestive System Diseases
DNA Virus Infections
Enterovirus Infections
Hepadnaviridae Infections
Hepatitis, Viral, Human
Liver Diseases
Parasitic Diseases
Picornaviridae Infections
Protozoan Infections
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
Engerix-B vaccine
Infanrix/Hib vaccine
Polio Sabin vaccine
Rotarix vaccine
Synflorix vaccine
Measles vaccine
Yellow fever vaccine
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services